Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting

  1. Van Der Kroef, M.
  2. Castellucci, M.
  3. Mokry, M.
  4. Cossu, M.
  5. Garonzi, M.
  6. Bossini-Castillo, L.M.
  7. Chouri, E.
  8. Wichers, C.G.K.
  9. Beretta, L.
  10. Trombetta, E.
  11. Silva-Cardoso, S.
  12. Vazirpanah, N.
  13. Carvalheiro, T.
  14. Angiolilli, C.
  15. Bekker, C.P.J.
  16. Affandi, A.J.
  17. Reedquist, K.A.
  18. Bonte-Mineur, F.
  19. Zirkzee, E.J.M.
  20. Bazzoni, F.
  21. Radstake, T.R.D.J.
  22. Rossato, M.
Revista:
Annals of the Rheumatic Diseases

ISSN: 1468-2060 0003-4967

Any de publicació: 2019

Volum: 78

Número: 4

Pàgines: 529-538

Tipus: Article

DOI: 10.1136/ANNRHEUMDIS-2018-214295 GOOGLE SCHOLAR